Drugs Made In America Acquisition LLC bought DMAA
January 29, 2025 · Form 4 insider transaction
Drugs Made In America Acquisition LLC bought 400,000 shares of Drugs Made In America Acquisition Corp., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
400,000
Price
N/A
Total value
N/A
Role—
SecurityOrdinary shares
Transaction codeP: Open-market purchase
Transaction dateJanuary 29, 2025
Filing dateFebruary 4, 2025
Shares owned after10,257,143
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the 400,000 private units owned by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $4,000,000.